Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Antonio Carlos Wolff,

Antonio Carlos Wolff,

The Johns Hopkins University USA

Linda A. deGraffenried

Linda A. deGraffenried

The University of Texas at Austin USA

Chang Gang

Chang Gang

Sun Yat-Sen University China

Marco Bernini

Marco Bernini

Careggi University Hospital, Florence Italy

Ragheed Al-Mufti

Ragheed Al-Mufti

The West of London Breast Cancer Network UK

Maude Hebert,

Maude Hebert,

University of Quebec in Trois-Rivieres Canada

Guan Chen

Guan Chen

Medical college of Wisconsin USA

Kim Jaffee

Kim Jaffee

Wayne State University USA

Breast Cancer 2020

About us

10th World Congress on Breast Cancer extends its welcome to you during April 20-21, 2020 at Berlin, Germany with a theme ‘’Determining The Possible Ways To Cure And Prevent Breast Cancer’’.

Breast Cancer 2020 Conference aims to bring together the Professors, Researchers, scientists, business giants and technocrats to provide an international forum for the dissemination of original research results, new ideas and practical development and discover advances in health practice, management and education in relation to health disparities as well as a breadth of other topics.

Importance & Scope:

Breast Cancer 2020  deals with Breast cancer knowledge and characteristics, Screening, Detecting and Diagnosing Breast Cancer, Breast cancer therapy, prevention and medicine, Surgery Choices for Breast Cancer, Personalized Medicine, Clinical trials of Breast Cancer, Male Breast Cancer and Breast cancer Nursing. Breast cancer is the main type of cancer from which most of the women are suffering worldwide. Awareness about the breast cancer risks, symptoms and treatment is very important. Introduction of new techniques in the field of medicine as well as diagnosis is going on worldwide. Breast Cancer Conference 2020 provide a platform for sharing of information about the breast cancer treatment techniques and newly developed techniques for the same as well as provide platform about the recent researches on breast cancer. This event includes prompt keynote presentations, oral talks, poster presentations and exhibitions.

 Why Berlin?

Berlin is the capital and the largest city of Germany as well as one of its 16 constituent states. It is the second most populous city proper and the seventh most populous urban area in the European Union.

Berlin is a world city of culture, politics, media and science. Its economy is based on high-tech firms and the service sector, encompassing a diverse range of creative industries, research facilities, media corporations and convention venues.

It’s also one of Europe’s successful researches, business and technology clusters is based at WISTA in Berlin-Adlershof, with more than 1,000 affiliated firms, university departments and scientific institutions.

Why to Attend???

It will provide exposure about the detailed information of Breast Cancer. It will also provide insight to the novel inventions and techniques. It is very beneficial for the students, physicians, nurses, doctors, health care people, professors because it provides knowledge in the field. It also gives opportunities to the Breast Cancer Societies in Germany to showcase their knowledge and have face to face meetings with scientists increasing their business opportunities. It also gives opportunity to know their market competitors.

Benefits:

Accepted abstracts will be published in Journal of Nursing and Healthcare and provided with DOI Global networking: In transferring and exchanging Ideas. A Unique Opportunity for Advertisers and Sponsors at this International event.

Target Audience:

Leading world Doctors, Directors, Deans, Professors, Associate Professors, Registered Nurses, Research Fellows, Instructors  and many more from leading universities, companies and medical research institutions, hospitals sharing their novel researches in the arena of Nursing, Healthcare & Medicine.

 

 

Sessions/Tracks

Track 1: Breast Cancer Staging

Breast cancer staging describes how much cancer is in the body which is treated with chemotherapy, hormone therapy, and drugs. It has both medical and pathologic staging systems for breast cancer. The pathologic stage also called the medical stage is determined by examining tissue removed during an operation. If surgery is not conceivable, sometimes right away cancer will be given a clinical stage instead. Imaging tests like x-rays, CT scans, MRIs, ultrasound, and PET scans may also give information about how much and where cancer is in the body. In the system called TNM, every cancer is assigned a letter or number to describe the tumor, node, and metastases. T stands for the original tumor, where T category gives information about aspects of the original (primary) tumor, such as its size whether it has grown into nearby tissues. N stands for nodes where category describes whether cancer has spread into nearby lymph nodes and M stands for metastasis in which this category tells whether cancer has spread to distant parts of the body. In stage grouping, once the values for T, N, and M have been determined, they are combined to assign an overall stage.

Related: European Breast Cancer Conferences | Breast cancer Summit 2020 | Cancer Conferences

34th Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 25-27, 2019 London, UK; 31st international conference on Cancer Research and therapy slated, September 09- 10, 2019  Zurich, Switzerland; 37th World Cancer Conference , October 10-11, 2019 Dublin, Ireland; 3rd Cancer Diagnostics & Treatment Conference , November 11-12 2019 Frankfurt, Germany; World Congress on Women Oncology & Care, November 18-19, 2019 Berlin, Germany; International Conference on Frontiers in Gynaecologic Cancers, November 18-19, 2019 Berlin, Germany; 5th World Congress on Cancer and Diagnostics, November 18 – 19, 2019 Rome, Italy; 17th International Conference on Cancer Research and Therapy, November 25-26, 2019 Valencia, Spain.

Related Societies:

Europe: European Society For Medical Oncology,Rational Therapy for Breast Cancer, European Society of Preventive Medicine , Association Vivre sans Thyroïde, Dutch Endocrine Society, European Laryngological Society, European Society of Endocrinology, French Endocrine Society, German Society of ORL HNS, German Thyroid Cancer Survivors’ Association.

Asia Pacific & Middle East: Asian Breast Cancer Society, Asian Health Coalition, Asian Cancer Foundation , Asian Pacific Prostate Society, Asia-Pacific Cancer Society, Asia Pacific NeuroEndocrine Tumor Society, Asian Society of Head & Neck Oncology, Asian and Oceania Thyroid Association, Asia-Pacific Society of Thyroid Surgery, Brazilian Society of Head and Neck Surgery .

America : American Association of Endocrine Surgeons, American Association of Clinical Endocrinologists, American Head and Neck Society, American Thyroid Association, Association of Women Surgeons, Australian and New Zealand Endocrine Surgeons, Australian Society of Otolaryngology Head & Neck Surgery, British Association of Head and Neck Oncology , Canadian  Association of Pathologists


Track 2: Breast Cancer Awareness

Breast cancer advocacy and awareness efforts are a type of advocacy. Breast cancer consciousness is an effort to raise awareness and reduce the stigma of breast cancer through education on symptoms and treatment whereas breast cancer advocates raise funds for more patient empowerment, better care, more knowledge, and by conducting educational campaigns or providing free or low-cost services. Breast cancer culture, at times called pink ribbon culture, the outgrowth of breast cancer advocacy, is the social movement that supports the larger women's health movement, socially aware, pro-woman individuals, businesses and governments to signal their support for women, health, and mainstream medicine. The environmental breast cancer drive suspects pollution as a substantial cause, possibly from pesticides, plastics, and industrial runoff in groundwater.

Related: Breast Cancer Conferences |Breast Cancer Conferences 2020 Europe | Breast cancer Summit 2020

34th Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 25-27, 2019 London, UK; 31st international conference on Cancer Research and therapy slated, September 09- 10, 2019  Zurich, Switzerland; 37th World Cancer Conference , October 10-11, 2019 Dublin, Ireland; 3rd Cancer Diagnostics & Treatment Conference , November 11-12 2019 Frankfurt, Germany; World Congress on Women Oncology & Care, November 18-19, 2019 Berlin, Germany; International Conference on Frontiers in Gynaecologic Cancers, November 18-19, 2019 Berlin, Germany; 5th World Congress on Cancer and Diagnostics, November 18 – 19, 2019 Rome, Italy; 17th International Conference on Cancer Research and Therapy, November 25-26, 2019 Valencia, Spain.

Related Societies:

Europe: European Society For Medical Oncology,Rational Therapy for Breast Cancer, European Society of Preventive Medicine , Association Vivre sans Thyroïde, Dutch Endocrine Society, European Laryngological Society, European Society of Endocrinology, French Endocrine Society, German Society of ORL HNS, German Thyroid Cancer Survivors’ Association.

Asia Pacific & Middle East: Asian Breast Cancer Society, Asian Health Coalition, Asian Cancer Foundation , Asian Pacific Prostate Society, Asia-Pacific Cancer Society, Asia Pacific NeuroEndocrine Tumor Society, Asian Society of Head & Neck Oncology, Asian and Oceania Thyroid Association, Asia-Pacific Society of Thyroid Surgery, Brazilian Society of Head and Neck Surgery .

America : American Association of Endocrine Surgeons, American Association of Clinical Endocrinologists, American Head and Neck Society, American Thyroid Association, Association of Women Surgeons, Australian and New Zealand Endocrine Surgeons, Australian Society of Otolaryngology Head & Neck Surgery, British Association of Head and Neck Oncology , Canadian  Association of Pathologists

 

Track 3: Breast Cancer Detection, Prevention, And Diagnosis

Early detection is always better and can be done through screening methods. If family history is there for breast cancer, then one should go for the advice of a doctor. Screening methods are medical breast examination (doctors or nurses examine women's breasts for lumps), mammography, and other imaging techniques. If the lump is there in the breast it can be breast cancer. X-rays are taken to closely observe the breast cancer which is known as a mammogram. After lump detection or other sign mammogram is used.

Related: Breast Cancer Conferences 2020 Europe | Breast Cancer Meetings | Cancer Conferences

34th Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 25-27, 2019 London, UK; 31st international conference on Cancer Research and therapy slated, September 09- 10, 2019  Zurich, Switzerland; 37th World Cancer Conference , October 10-11, 2019 Dublin, Ireland; 3rd Cancer Diagnostics & Treatment Conference , November 11-12 2019 Frankfurt, Germany; World Congress on Women Oncology & Care, November 18-19, 2019 Berlin, Germany; International Conference on Frontiers in Gynaecologic Cancers, November 18-19, 2019 Berlin, Germany; 5th World Congress on Cancer and Diagnostics, November 18 – 19, 2019 Rome, Italy; 17th International Conference on Cancer Research and Therapy, November 25-26, 2019 Valencia, Spain.

Related Societies:

Europe: European Society For Medical Oncology, Rational Therapy for Breast Cancer, European Society of Preventive Medicine , Association Vivre sans Thyroïde, Dutch Endocrine Society, European Laryngological Society, European Society of Endocrinology, French Endocrine Society, German Society of ORL HNS, German Thyroid Cancer Survivors’ Association.

Asia Pacific & Middle East: Asian Breast Cancer Society, Asian Health Coalition, Asian Cancer Foundation , Asian Pacific Prostate Society, Asia-Pacific Cancer Society, Asia Pacific NeuroEndocrine Tumor Society, Asian Society of Head & Neck Oncology, Asian and Oceania Thyroid Association, Asia-Pacific Society of Thyroid Surgery, Brazilian Society of Head and Neck Surgery .

America : American Association of Endocrine Surgeons, American Association of Clinical EndocrinologistsAmerican Head and Neck Society, American Thyroid Association, Association of Women Surgeons, Australian and New Zealand Endocrine Surgeons, Australian Society of Otolaryngology Head & Neck Surgery, British Association of Head and Neck Oncology , Canadian  Association of Pathologists

 

Track 4: Breast Cancer Surgery

Most of the women suffering from breast cancer have to face breast surgery as a part of treatment. Different ins and outs are there due to which breast surgery is done: to remove cancer cells consist of breast-conserving surgery and mastectomy, to find whether cancer is spreading or spread already including a biopsy or axillary lymph node dissection, after removal of cancer for resorting the shape of the breast that is breast reconstruction. Surgery side effects are there.

Related: Breast Cancer Conferences | Breast Cancer Meetings | Breast Cancer Events

34th Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 25-27, 2019 London, UK; 31st international conference on Cancer Research and therapy slated, September 09- 10, 2019  Zurich, Switzerland; 37th World Cancer Conference , October 10-11, 2019 Dublin, Ireland; 3rd Cancer Diagnostics & Treatment Conference , November 11-12 2019 Frankfurt, Germany; World Congress on Women Oncology & Care, November 18-19, 2019 Berlin, Germany; International Conference on Frontiers in Gynaecologic Cancers, November 18-19, 2019 Berlin, Germany; 5th World Congress on Cancer and Diagnostics, November 18 – 19, 2019 Rome, Italy; 17th International Conference on Cancer Research and Therapy, November 25-26, 2019 Valencia, Spain.

Related Societies:

Europe: European Society For Medical Oncology,Rational Therapy for Breast Cancer, European Society of Preventive Medicine Association Vivre sans Thyroïde, Dutch Endocrine Society, European Laryngological Society, European Society of Endocrinology, French Endocrine Society, German Society of ORL HNS, German Thyroid Cancer Survivors’ Association.

Asia Pacific & Middle East: Asian Breast Cancer Society, Asian Health Coalition, Asian Cancer Foundation Asian Pacific Prostate Society, Asia-Pacific Cancer Society, Asia Pacific NeuroEndocrine Tumor Society, Asian Society of Head & Neck Oncology, Asian and Oceania Thyroid Association, Asia-Pacific Society of Thyroid Surgery, Brazilian Society of Head and Neck Surgery .

America : American Association of Endocrine Surgeons, American Association of Clinical Endocrinologists, American Head and Neck Society, American Thyroid Association, Association of Women Surgeons, Australian and New Zealand Endocrine Surgeons, Australian Society of Otolaryngology Head & Neck Surgery, British Association of Head and Neck Oncology , Canadian  Association of Pathologists

 

Track 5: Male Breast Cancer Research

Men are having a small amount of breast tissue, during puberty in girls tissue grow and develops but in men, it doesn’t. As breast tissue is there in men additionally, they can also get breast cancer like in women. Most of the men are not aware of this and the treatment of breast cancer males is mostly delayed as compared to females because of unawareness. So many things are there that raise breast cancer in men like if any female in the family or close relative is having cancer, radiation exposure to the chest, Klinefelter's syndrome, etc. Symptoms of breast cancer are the same in men like women. Awareness should be there so that we can save our lives.

Related: Breast Cancer Conferences 2020 Europe   |Breast cancer Summit 2020Breast Cancer Events

34th Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 25-27, 2019 London, UK; 31st international conference on Cancer Research and therapy slated, September 09- 10, 2019  Zurich, Switzerland; 37th World Cancer Conference , October 10-11, 2019 Dublin, Ireland; 3rd Cancer Diagnostics & Treatment Conference , November 11-12 2019 Frankfurt, Germany; World Congress on Women Oncology & Care, November 18-19, 2019 Berlin, Germany; International Conference on Frontiers in Gynaecologic Cancers, November 18-19, 2019 Berlin, Germany; 5th World Congress on Cancer and Diagnostics, November 18 – 19, 2019 Rome, Italy; 17th International Conference on Cancer Research and Therapy, November 25-26, 2019 Valencia, Spain.

Related Societies:

Europe: European Society For Medical Oncology, Rational Therapy for Breast Cancer, European Society of Preventive Medicine , Association Vivre sans Thyroïde, Dutch Endocrine Society, European Laryngological Society, European Society of Endocrinology, French Endocrine Society, German Society of ORL HNS, German Thyroid Cancer Survivors’ Association.

Asia Pacific & Middle East: Asian Breast Cancer Society, Asian Health Coalition, Asian Cancer Foundation Asian Pacific Prostate Society, Asia-Pacific Cancer Society, Asia Pacific NeuroEndocrine Tumor Society, Asian Society of Head & Neck Oncology, Asian and Oceania Thyroid AssociationAsia-Pacific Society of Thyroid Surgery, Brazilian Society of Head and Neck Surgery .

America : American Association of Endocrine Surgeons, American Association of Clinical Endocrinologists, American Head and Neck Society, American Thyroid Association, Association of Women Surgeons, Australian and New Zealand Endocrine Surgeons, Australian Society of Otolaryngology Head & Neck Surgery, British Association of Head and Neck Oncology , Canadian  Association of Pathologists

 

Track 6: Breast Cancer And Cell Biology

Cancer cells are very complex cells and it is challenging for clinicians to manage breast cancer therapy. Tumor cells are having different phenotypes and deregulated apoptotic and these characteristics are responsible for improper therapeutic response. For multidrug resistance events major role is played by membrane transporters, they are the cell’s first line of contact with anticancer drugs. So cell structure and biological properties of the cell leads to drug-resistant and lead to a decrease in the intracellular activity of drugs. Breast growth is regulated by the interaction between hormones and growth factors. Genetic changes in growth factor can lead to abnormalities. The immune system of host play a substantial role during breast cancer, breast cancer is a complex disease.

 

Related: European Breast Cancer Conferences | Breast cancer Summit 2020 | Breast Cancer Events

34th Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 25-27, 2019 London, UK; 31st international conference on Cancer Research and therapy slated, September 09- 10, 2019  Zurich, Switzerland; 37th World Cancer Conference , October 10-11, 2019 Dublin, Ireland; 3rd Cancer Diagnostics & Treatment Conference , November 11-12 2019 Frankfurt, Germany; World Congress on Women Oncology & Care, November 18-19, 2019 Berlin, Germany; International Conference on Frontiers in Gynaecologic Cancers, November 18-19, 2019 Berlin, Germany; 5th World Congress on Cancer and Diagnostics, November 18 – 19, 2019 Rome, Italy; 17th International Conference on Cancer Research and Therapy, November 25-26, 2019 Valencia, Spain.

Related Societies:

Europe: European Society For Medical Oncology, Rational Therapy for Breast Cancer, European Society of Preventive Medicine , Association Vivre sans Thyroïde, Dutch Endocrine SocietyEuropean Laryngological Society, European Society of Endocrinology, French Endocrine Society, German Society of ORL HNS, German Thyroid Cancer Survivors’ Association.

Asia Pacific & Middle East: Asian Breast Cancer Society, Asian Health Coalition, Asian Cancer Foundation , Asian Pacific Prostate Society, Asia-Pacific Cancer Society, Asia Pacific NeuroEndocrine Tumor Society, Asian Society of Head & Neck Oncology, Asian and Oceania Thyroid Association, Asia-Pacific Society of Thyroid Surgery, Brazilian Society of Head and Neck Surgery .

America : American Association of Endocrine Surgeons, American Association of Clinical Endocrinologists, American Head and Neck Society, American Thyroid Association, Association of Women Surgeons, Australian and New Zealand Endocrine Surgeons, Australian Society of Otolaryngology Head & Neck Surgery, British Association of Head and Neck Oncology , Canadian  Association of Pathologists

Track 7: Breast Cancer And Immunology

Immunotherapy improves the aftereffect of clinical treatment in breast cancer patients. Targeted treatment is the approach used to directly target tumor cells, side effects of immunotherapy can be decreased.

Related: Breast Cancer Conferences | Breast Cancer Meetings | Breast Cancer Events

34th Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 25-27, 2019 London, UK; 31st international conference on Cancer Research and therapy slated, September 09- 10, 2019  Zurich, Switzerland; 37th World Cancer Conference , October 10-11, 2019 Dublin, Ireland; 3rd Cancer Diagnostics & Treatment Conference , November 11-12 2019 Frankfurt, Germany; World Congress on Women Oncology & Care, November 18-19, 2019 Berlin, Germany; International Conference on Frontiers in Gynaecologic Cancers, November 18-19, 2019 Berlin, Germany; 5th World Congress on Cancer and Diagnostics, November 18 – 19, 2019 Rome, Italy; 17th International Conference on Cancer Research and Therapy, November 25-26, 2019 Valencia, Spain.

Related Societies:

Europe: European Society For Medical Oncology, Rational Therapy for Breast Cancer, European Society of Preventive Medicine , Association Vivre sans Thyroïde, Dutch Endocrine Society, European Laryngological Society, European Society of Endocrinology, French Endocrine Society, German Society of ORL HNS, German Thyroid Cancer Survivors’ Association.

Asia Pacific & Middle East: Asian Breast Cancer Society, Asian Health Coalition, Asian Cancer Foundation , Asian Pacific Prostate Society, Asia-Pacific Cancer Society, Asia Pacific NeuroEndocrine Tumor Society, Asian Society of Head & Neck Oncology, Asian and Oceania Thyroid Association, Asia-Pacific Society of Thyroid Surgery, Brazilian Society of Head and Neck Surgery .

America : American Association of Endocrine Surgeons, American Association of Clinical Endocrinologists, American Head and Neck Society, American Thyroid Association, Association of Women Surgeons, Australian and New Zealand Endocrine Surgeons, Australian Society of Otolaryngology Head & Neck Surgery, British Association of Head and Neck Oncology , Canadian  Association of Pathologists

Track 8: Breast Cancer Nursing

Nurses play an important role during the treatment of breast cancer because they can help the patient to build physically and mentally. They can educate patients about risk factors, ways to reduce them. Nurses involved in breast cancer care have an impact on the early discovery of breast cancer, treatment, and they serve as advocates for women with the disease.

Related: European Breast Cancer Conferences |Breast Cancer Meetings |Breast Cancer Conferences 2020 Europe

34th Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 25-27, 2019 London, UK; 31st international conference on Cancer Research and therapy slated, September 09- 10, 2019  Zurich, Switzerland; 37th World Cancer Conference , October 10-11, 2019 Dublin, Ireland; 3rd Cancer Diagnostics & Treatment Conference , November 11-12 2019 Frankfurt, Germany; World Congress on Women Oncology & Care, November 18-19, 2019 Berlin, Germany; International Conference on Frontiers in Gynaecologic Cancers, November 18-19, 2019 Berlin, Germany; 5th World Congress on Cancer and Diagnostics, November 18 – 19, 2019 Rome, Italy; 17th International Conference on Cancer Research and Therapy, November 25-26, 2019 Valencia, Spain.

Related Societies:

Europe: European Society For Medical Oncology, Rational Therapy for Breast Cancer, European Society of Preventive Medicine , Association Vivre sans Thyroïde, Dutch Endocrine SocietyEuropean Laryngological Society, European Society of Endocrinology, French Endocrine Society, German Society of ORL HNS, German Thyroid Cancer Survivors’ Association.

Asia Pacific & Middle East: Asian Breast Cancer Society, Asian Health Coalition, Asian Cancer Foundation , Asian Pacific Prostate Society, Asia-Pacific Cancer Society, Asia Pacific NeuroEndocrine Tumor Society, Asian Society of Head & Neck Oncology, Asian and Oceania Thyroid Association, Asia-Pacific Society of Thyroid Surgery, Brazilian Society of Head and Neck Surgery .

America : American Association of Endocrine Surgeons, American Association of Clinical Endocrinologists, American Head and Neck Society, American Thyroid Association, Association of Women Surgeons, Australian and New Zealand Endocrine Surgeons, Australian Society of Otolaryngology Head & Neck Surgery, British Association of Head and Neck Oncology , Canadian  Association of Pathologists

 

Track 9: Breast Cancer Management

Breast cancer management takes different approaches that depend on the physical and biological characteristics of the disease, age, overall health and personal preferences of the patient. There are 2 types of treatment classified into local therapy (surgery and radiotherapy) and systemic treatment (chemo-, endocrine, and targeted therapies). The mainstay of breast cancer management is surgery for the local and regional tumor, followed by a combination of chemotherapy, radiotherapy, endocrine therapy, and targeted therapy. Radiation treatment includes utilizing high-vitality X-rays or Gamma rays that target a tumor or post-surgery tumor site. Cryoablation trial treatments accessible for women with small or early-stage breast cancer. The rejuvenation of the breast after breast cancer surgery is included in holistic approaches to cancer management to address identity and expressive aspects of the disease whereas reconstruction can take place at the same time as cancer-removing surgery, takes to an inordinate length of time later so some women decide not to have reconstruction and they opt for a prosthesis instead. Epidemiologic risk factors vary by the hormone receptor expression of the breast cancer divided into preventable and non-preventable. Their study belongs in the field of epidemiology.

Related: European Breast Cancer Conferences | Breast cancer Summit 2020 | Breast Cancer Events

34th Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 25-27, 2019 London, UK; 31st international conference on Cancer Research and therapy slated, September 09- 10, 2019  Zurich, Switzerland; 37th World Cancer Conference , October 10-11, 2019 Dublin, Ireland; 3rd Cancer Diagnostics & Treatment Conference , November 11-12 2019 Frankfurt, Germany; World Congress on Women Oncology & Care, November 18-19, 2019 Berlin, Germany; International Conference on Frontiers in Gynaecologic Cancers, November 18-19, 2019 Berlin, Germany; 5th World Congress on Cancer and Diagnostics, November 18 – 19, 2019 Rome, Italy; 17th International Conference on Cancer Research and Therapy, November 25-26, 2019 Valencia, Spain.

Related Societies:

Europe: European Society For Medical Oncology, Rational Therapy for Breast Cancer, European Society of Preventive Medicine , Association Vivre sans Thyroïde, Dutch Endocrine SocietyEuropean Laryngological Society, European Society of Endocrinology, French Endocrine Society, German Society of ORL HNSGerman Thyroid Cancer Survivors’ Association.

Asia Pacific & Middle East: Asian Breast Cancer Society, Asian Health Coalition, Asian Cancer Foundation , Asian Pacific Prostate Society, Asia-Pacific Cancer Society, Asia Pacific NeuroEndocrine Tumor Society, Asian Society of Head & Neck Oncology, Asian and Oceania Thyroid Association, Asia-Pacific Society of Thyroid Surgery, Brazilian Society of Head and Neck Surgery .

America : American Association of Endocrine Surgeons, American Association of Clinical Endocrinologists, American Head and Neck Society, American Thyroid Association, Association of Women SurgeonsAustralian and New Zealand Endocrine Surgeons, Australian Society of Otolaryngology Head & Neck Surgery, British Association of Head and Neck Oncology , Canadian  Association of Pathologists


Track 10: Epidemiology Of Breast Cancer And Risk Factors

Breast cancer incidence rates increase sharply with age, becoming substantial before the age of 50 years. Major risk factors that occur are during the premenopausal years, the rate of increase in incidence is common around the world, approximately 8%-9% per year, breastfeeding each child for less than 6 months, and physical inactivity, are each linked to an estimated 3% of female breast cancer cases. Some other factors include oral contraceptives; hormone replacement therapy, ionizing radiation, and diethylstilboestrol use in pregnancy are causes of breast cancer and lifestyle factors including overweight and obesity, alcohol and certain occupational exposures. Breast cancer, like other forms of cancer, can result from multiple environmental and hereditary risk factors like individual person's development, exposure to microbes, medical interventions, and dietary exposures to nutrients, energy and toxicants, chemicals from industrial, agricultural processes and from consumer products.

Related: Breast Cancer Meetings | Cancer Conferences | Breast Cancer Conferences 2020 Europe

34th Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 25-27, 2019 London, UK; 31st international conference on Cancer Research and therapy slated, September 09- 10, 2019  Zurich, Switzerland; 37th World Cancer Conference , October 10-11, 2019 Dublin, Ireland; 3rd Cancer Diagnostics & Treatment Conference , November 11-12 2019 Frankfurt, Germany; World Congress on Women Oncology & Care, November 18-19, 2019 Berlin, Germany; International Conference on Frontiers in Gynaecologic Cancers, November 18-19, 2019 Berlin, Germany; 5th World Congress on Cancer and Diagnostics, November 18 – 19, 2019 Rome, Italy; 17th International Conference on Cancer Research and Therapy, November 25-26, 2019 Valencia, Spain.

Related Societies:

Europe: European Society For Medical Oncology, Rational Therapy for Breast Cancer, European Society of Preventive Medicine , Association Vivre sans Thyroïde, Dutch Endocrine Society, European Laryngological SocietyEuropean Society of Endocrinology, French Endocrine Society, German Society of ORL HNS, German Thyroid Cancer Survivors’ Association.

Asia Pacific & Middle East: Asian Breast Cancer Society, Asian Health Coalition, Asian Cancer Foundation , Asian Pacific Prostate Society, Asia-Pacific Cancer Society, Asia Pacific NeuroEndocrine Tumor Society, Asian Society of Head & Neck Oncology, Asian and Oceania Thyroid Association, Asia-Pacific Society of Thyroid Surgery, Brazilian Society of Head and Neck Surgery .

America : American Association of Endocrine Surgeons, American Association of Clinical Endocrinologists, American Head and Neck Society, American Thyroid Association, Association of Women SurgeonsAustralian and New Zealand Endocrine Surgeons, Australian Society of Otolaryngology Head & Neck Surgery, British Association of Head and Neck Oncology , Canadian  Association of Pathologists


Track 11: Inflammatory Breast Cancer

One of the most aggressive types of breast cancer occurring in women of any age is inflammatory breast cancer. The typical presentation is rapid swelling, sometimes associated with skin changes, persistent itching rapid increase in breast size, redness and nipple retraction. It is often regarded as systemic cancer. Breast cancer is diagnosed by a biopsy where it confirms as malignancy Ultrasound is useful for looking at some breast changes, such as lumps or changes in women with dense breast tissue especially those that can be felt but not seen on a mammogram that are best breast cancer screening tests. All Inflammatory breast cancers start as Stage IIIB since they involve the skin but if cancer has spread to lymph nodes around the collarbone or inside the chest, its stage IIIC and cancer that has spread outside the breast and nearby lymph nodes it is stage IV.

Related: European Breast Cancer Conferences | Breast cancer Summit 2020 |  Cancer Events

34th Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 25-27, 2019 London, UK; 31st international conference on Cancer Research and therapy slated, September 09- 10, 2019  Zurich, Switzerland; 37th World Cancer Conference , October 10-11, 2019 Dublin, Ireland; 3rd Cancer Diagnostics & Treatment Conference , November 11-12 2019 Frankfurt, Germany; World Congress on Women Oncology & Care, November 18-19, 2019 Berlin, Germany; International Conference on Frontiers in Gynaecologic Cancers, November 18-19, 2019 Berlin, Germany; 5th World Congress on Cancer and Diagnostics, November 18 – 19, 2019 Rome, Italy; 17th International Conference on Cancer Research and Therapy, November 25-26, 2019 Valencia, Spain.

Related Societies:

Europe: European Society For Medical Oncology,Rational Therapy for Breast Cancer, European Society of Preventive Medicine , Association Vivre sans Thyroïde, Dutch Endocrine SocietyEuropean Laryngological Society, European Society of Endocrinology, French Endocrine Society, German Society of ORL HNS, German Thyroid Cancer Survivors’ Association.

Asia Pacific & Middle East: Asian Breast Cancer Society, Asian Health Coalition, Asian Cancer Foundation , Asian Pacific Prostate Society, Asia-Pacific Cancer Society, Asia Pacific NeuroEndocrine Tumor Society, Asian Society of Head & Neck Oncology, Asian and Oceania Thyroid Association, Asia-Pacific Society of Thyroid Surgery, Brazilian Society of Head and Neck Surgery .

America : American Association of Endocrine Surgeons, American Association of Clinical Endocrinologists, American Head and Neck Society, American Thyroid Association, Association of Women Surgeons, Australian and New Zealand Endocrine Surgeons, Australian Society of Otolaryngology Head & Neck Surgery, British Association of Head and Neck Oncology , Canadian  Association of Pathologists

 

Track 12: Mammography

Mammograms can help in saving lives by detecting breast cancer early. The women who are not having any sign and symptoms of breast cancer can also go for mammography, this is known as a primary mammogram. During screening mammogram, two or more X-rays pictures are taken of each breast. Microcalcification can be detecting using screening mammography that indicates the presence of Breast Cancer. A diagnostic mammogram can be used after screening mammogram to investigate the symptoms in details that are detected in screening mammogram. Mammography related controversies are also there because of False-positive results, over diagnosis, and overtreatment, False-negative results, Radiation exposure, etc. Screening mammogram and Diagnostic mammogram

Related: Breast Cancer Conferences | Breast Cancer Meetings | Breast Cancer Events

34th Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 25-27, 2019 London, UK; 31st international conference on Cancer Research and therapy slated, September 09- 10, 2019  Zurich, Switzerland; 37th World Cancer Conference , October 10-11, 2019 Dublin, Ireland; 3rd Cancer Diagnostics & Treatment Conference , November 11-12 2019 Frankfurt, Germany; World Congress on Women Oncology & Care, November 18-19, 2019 Berlin, Germany; International Conference on Frontiers in Gynaecologic Cancers, November 18-19, 2019 Berlin, Germany; 5th World Congress on Cancer and Diagnostics, November 18 – 19, 2019 Rome, Italy; 17th International Conference on Cancer Research and Therapy, November 25-26, 2019 Valencia, Spain.

Related Societies:

Europe: European Society For Medical Oncology, Rational Therapy for Breast Cancer, European Society of Preventive Medicine , Association Vivre sans Thyroïde, Dutch Endocrine Society, European Laryngological Society, European Society of Endocrinology, French Endocrine Society, German Society of ORL HNS, German Thyroid Cancer Survivors’ Association.

Asia Pacific & Middle East: Asian Breast Cancer Society, Asian Health Coalition, Asian Cancer Foundation , Asian Pacific Prostate Society, Asia-Pacific Cancer Society, Asia Pacific NeuroEndocrine Tumor Society, Asian Society of Head & Neck Oncology, Asian and Oceania Thyroid Association, Asia-Pacific Society of Thyroid Surgery, Brazilian Society of Head and Neck Surgery .

America : American Association of Endocrine Surgeons, American Association of Clinical Endocrinologists, American Head and Neck Society, American Thyroid Association, Association of Women Surgeons, Australian and New Zealand Endocrine Surgeons, Australian Society of Otolaryngology Head & Neck Surgery, British Association of Head and Neck Oncology , Canadian  Association of Pathologists

 

Track 13: Diet and Lifestyle Effect On Breast Cancer

A healthy diet and maintaining weight can reduce the risk of breast cancer. Smoking during early adulthood and adolescence can increase the risk of breast cancer in the latter stage of life. Eating plant-based food and reducing the alcohol consumption helps in prevention of Breast Cancer. Physical activities particularly after menopause like cycling, walking, playing with children helps in reducing the risk of breast cancer. Breastfeeding also reduces the risk of breast cancer. Hormone replacement therapy, use the contraceptive pill can increase the menace of breast cancer. Pregnancy also affects breast cancer; women who are starting their family early are at lower breast cancer risk than the women who are giving birth at a late age.

Related: Breast Cancer Conferences 2020 Europe | Breast cancer Summit 2020Cancer Conferences

34th Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 25-27, 2019 London, UK; 31st international conference on Cancer Research and therapy slated, September 09- 10, 2019  Zurich, Switzerland; 37th World Cancer Conference , October 10-11, 2019 Dublin, Ireland; 3rd Cancer Diagnostics & Treatment Conference , November 11-12 2019 Frankfurt, Germany; World Congress on Women Oncology & Care, November 18-19, 2019 Berlin, Germany; International Conference on Frontiers in Gynaecologic Cancers, November 18-19, 2019 Berlin, Germany; 5th World Congress on Cancer and Diagnostics, November 18 – 19, 2019 Rome, Italy; 17th International Conference on Cancer Research and Therapy, November 25-26, 2019 Valencia, Spain.

Related Societies:

Europe: European Society For Medical Oncology, Rational Therapy for Breast Cancer, European Society of Preventive Medicine , Association Vivre sans Thyroïde, Dutch Endocrine Society, European Laryngological SocietyEuropean Society of Endocrinology, French Endocrine Society, German Society of ORL HNS, German Thyroid Cancer Survivors’ Association.

Asia Pacific & Middle East: Asian Breast Cancer Society, Asian Health Coalition, Asian Cancer Foundation , Asian Pacific Prostate Society, Asia-Pacific Cancer Society, Asia Pacific NeuroEndocrine Tumor Society, Asian Society of Head & Neck Oncology, Asian and Oceania Thyroid Association, Asia-Pacific Society of Thyroid SurgeryBrazilian Society of Head and Neck Surgery .

America : American Association of Endocrine Surgeons, American Association of Clinical Endocrinologists, American Head and Neck Society, American Thyroid Association, Association of Women Surgeons, Australian and New Zealand Endocrine Surgeons, Australian Society of Otolaryngology Head & Neck Surgery, British Association of Head and Neck Oncology , Canadian  Association of Pathologists


Track 14: Breast Cancer Risk

According to the studies combination of factors are responsible for breast cancer risk. The main factor is age, most of the breast cancer cases noticed in women with age 50 or older, Genetic mutations are also risk factor behind breast cancer. Mutations in certain genes like BRCA1 and BRCA2 can go from one generation to other generation and it can increase the risk of breast cancer.

Related: Breast cancer Summit 2020 | Breast Cancer Conferences 2020 Europe | Cancer Events

34th Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 25-27, 2019 London, UK; 31st international conference on Cancer Research and therapy slated, September 09- 10, 2019  Zurich, Switzerland; 37th World Cancer Conference , October 10-11, 2019 Dublin, Ireland; 3rd Cancer Diagnostics & Treatment Conference , November 11-12 2019 Frankfurt, Germany; World Congress on Women Oncology & Care, November 18-19, 2019 Berlin, Germany; International Conference on Frontiers in Gynaecologic Cancers, November 18-19, 2019 Berlin, Germany; 5th World Congress on Cancer and Diagnostics, November 18 – 19, 2019 Rome, Italy; 17th International Conference on Cancer Research and Therapy, November 25-26, 2019 Valencia, Spain.

Related Societies:

Europe: European Society For Medical Oncology, Rational Therapy for Breast Cancer, European Society of Preventive Medicine , Association Vivre sans Thyroïde, Dutch Endocrine Society, European Laryngological Society, European Society of Endocrinology, French Endocrine Society, German Society of ORL HNS, German Thyroid Cancer Survivors’ Association.

Asia Pacific & Middle East: Asian Breast Cancer Society, Asian Health Coalition, Asian Cancer Foundation , Asian Pacific Prostate Society, Asia-Pacific Cancer Society, Asia Pacific NeuroEndocrine Tumor Society, Asian Society of Head & Neck Oncology, Asian and Oceania Thyroid Association, Asia-Pacific Society of Thyroid Surgery, Brazilian Society of Head and Neck Surgery .

America : American Association of Endocrine Surgeons, American Association of Clinical Endocrinologists, American Head and Neck Society, American Thyroid Association, Association of Women Surgeons, Australian and New Zealand Endocrine Surgeons, Australian Society of Otolaryngology Head & Neck Surgery, British Association of Head and Neck Oncology , Canadian  Association of Pathologists

Market Analysis

Market Analysis of Breast Cancer

Breast cancer is a cancer that forms in the cells of the breasts. Breast cancer can occur in women and rarely in men. The symptoms of the breast cancer include a lump in the breast, bloody discharge from the nipple, changes in shape and size of the nipple or breast. There are 2 types of breast cancer: Non-invasive cancers stay within the milk ducts or lobules in the breast. They do not grow or invade in normal tissues within or beyond the breast. Non-invasive cancers are called as carcinoma in situ (in the same place) or pre-cancers. Invasive cancers do grow in normal, healthy tissues. Most breast cancers are invasive. Depending upon the type of cancer the treatment is determined, i.e., whether it is invasive or non-invasive cancer. Treatment varies depending upon the stage of cancer. It may consist of chemotherapy, surgery or radiation.

Early detection of breast cancer greatly increases the chances of successful treatment and saves the life. There are 2 major components of early detection of breast cancer: educate to promote early diagnosis and screening. There are 3 different types of screening tests available; they are the mammogram, clinical breast exam (CBE) and MRI (magnetic resonance imaging).

 

Is Breast Cancer a Modern Illness?

Ancient Egyptians were the first to diagnose, treat and prevent breast cancer more than 3,500 years ago. Breast cancer is now the most well-known and researched cancers in the medical world today. People diagnosed with breast cancer at an early stage have a very good chance of a cancer-free future. But this was not the case earlier. The first case of any type of cancer documented in Egypt was a breast cancer in 1600 BC. Edwin Smith Papyrus, an ancient text found in 1860 in an Egyptian tomb, described 8 cases of ulcers or tumors of the breast. The first doctor, who attempted to treat this type of cancer, wrote: “There is no treatment!” Physicians and medical researchers in ancient period posited the following theories regarding the cause of the breast cancer: humoralism, punishment, divine, lack of sexual activity, physical injuries, fear of breast cancer, without the benefit of 21st-century diagnostics. In ancient times, they used to call it “the wandering womb” where they believed that the uterus could move throughout the body leaving health problems of every kind in its wake. It was not diagnosed until the 19th century, unless and until the cases of breast cancer increased. But the disease is somewhat controlled with improvement in sanitation and hence the lifespan of an individual is increased.

The first successful treatment for breast cancer was done by French surgeon Jean Louis Petit and later Scottish surgeon Benjamin Bell where the lymph nodes, breast tissue, and chest muscle are removed surgically. Surgeon William Stewart Halsted began performing and perfecting mastectomies around 1882. Halsted’s mastectomies were invasive where breasts, lymph nodes, and underlying muscles are being removed and the procedure was deemed necessary to prevent cancer from recurring but often left patients with severe pain and disability.

By the 1970’s, researchers began to develop lumpectomy- more limited surgery to remove only the cancerous tumor and any surrounding tissue affected by the tumor.

By 1985, researchers found that radiation followed by lumpectomy gave a chance of survival equal to the considerably move invasive mastectomy.

Around the 20th century, doctors used radiation therapy to shrink the cancerous cells. Chemotherapy became an option. It helped to shrink cancerous cells before surgery and prevent recurrence after surgery and treat cancer that is metastasized or has spread to other parts of the body. Scientists began to experiment with combined treatments to improve outcomes. Throughout the 1970’s, this procedure has been continued and this led to a better understanding of how cancer can develop and spread throughout the body. This understanding led to the development of more effective targeted treatments. This approach to treat cancer and research is still continuing today.

In 1923, the first large-scale review of women with breast cancer was done by English scientist Janet Lane-Claypon, which identified several risk factors that are still considered today.

In 1980’s and 1990’s, thousands of women undergoing breast cancer treatment and high dose bone marrow transplants hoping to have a good result, which turned it to a disaster after the loss of 15-20% of women’s life due to the treatment.

In 1995 report from the Nurses’ Health Study and 2002 results of research from the Women’s Health Initiative concluded that hormone replacement therapies which had become popular among menopausal women could significantly increase the risk of breast cancer.

In the late 1990’s, scientists found that certain variants of the genes BRCA1 and BRCA2 are associated with 80% of breast cancer risk. Some women who discover this gene mutation within their genetic makeup will take proactive steps to reduce their risk of cancer, including preemptive mastectomies and even hysterectomies.

As scientists deepen their understanding of the role of genetics in breast cancer risk, research on developing new techniques has been increased. Meanwhile, some research is being done on repair or even replaces harmful genes before breast cancer occurs.

As research continues to improve, there are several chances of every person to survive and can prevent breast cancer or any type of cancer. Taking healthy food, avoiding alcohol and smoking may be an important precaution from developing cancer. Regular self-exams and annual mammograms after 40 years old are recommended.

What’s New in Breast Cancer Research?

Treatments are being evaluated in trails. This includes individual drugs, the combination of drugs, surgical and radiation techniques.  Investigations include new types of cancer vaccines, targeted therapy, oncolytic virotherapy, and immunotherapy.

The latest research is reported annually at scientific meetings such as the American Society of Clinical Oncology, San Antonio Breast Cancer Symposium and St. Galen Oncology Conference, Switzerland. These studies are reviewed by professional societies and other organizations and formulated into guidelines for specific treatment groups and risk category.

Fenretinide, a retinoid (drugs related to vitamin A), is also being studied as a way to reduce the risk of breast cancer.

Cryoablation

As of 2014, cryoablation is being studied to see whether it could be the subtitle for lumpectomy in small cancers. There is tentative evidence in those with tumors less than 2 centimeters. It can also be used for those, surgery is not possible. Another review stated that cryoablation looks promising for early breast cancer of small size.

 

Breast cancer cell lines

A considerable part of the current knowledge on breast carcinomas is based on in vivo and in vitro studies, performed with cell lines derived from breast cancers. These provide an unlimited source of homogenous, self-replicating material, free of contaminating stromal cells and often easily cultured in simple standard media. The first breast cancer line described was BT-20, established in 1958. Since then, despite sustained work in this area, the number of permanent lines obtained has been strikingly low. Indeed, attempts to culture breast cancer cell lines from primary tumors have been largely unsuccessful. This poor efficiency was often due to technical difficulties associated with the extraction of viable tumor cells from their surrounding stroma. Most of the available breast cancer lines issued from metastatic tumors, mainly from a pleural effusion. Effusions provided generally large numbers of dissociated, viable tumor cells with little or no contamination by fibroblasts and other tumor stroma cells. Many of the currently used BCC lines were established in the late 1970’s. a very few of them, namely MCF-7, T-47D, and MDA-MB-231, account for more than two-thirds of all abstracts reporting studies on mentioned breast cancer cell lines, as concluded from a Medline-based survey.

Molecular markers

Transcription Factors

NFTA transcription factors are implicated in breast cancer, more specifically in the process of cell motility at the basis of metastasis formation. Indeed, NFAT1 (NFATC2) and NFAT5 are pro invasive and promigratory in breast carcinoma and NFAT3 (NFATC4) is an inhibitor of cell motility. NFAT1 regulates the expression of the TWEAKR and its ligand TWEAK with the Lipocalin 2 to increase breast cancer cell invasion and NFAT3 inhibits Lipocalin 2 expression to blunt the cell invasion.

Metabolic markers

Clinically, the most useful metabolic markers in breast cancer are the estrogen and progesterone receptors that are used to predict response to hormone therapy. New or potentially new markers for breast cancer include BRCA1 and BRCA2 to identify patients at high risk of developing breast cancer, HER2 and SCD1 for predicting response to therapeutic regimens and urokinase plasminogen activator, PA1-1 and SCD1 for assessing prognosis.

Survey Report

Breast cancer is the second leading cancer in women worldwide, with nearly 1.7 million new cases diagnosed in 2012. Breast cancer is most common after menopause. American Cancer Society, for the year 2016 estimates that about 252,710 new cases of invasive breast cancer will be diagnosed in women, about 63,410 new cases of carcinoma in situ (CIS) will be diagnosed and about 40,601 women will die from breast cancer.

Breast Cancer Market Analysis

 

Trends in breast cancer incidence

Incidence rates vary from 19.3 per 100 000 women in Eastern Africa to 89.9 per 100 000 women in Western Europe and are high in developed regions of the world (more than 80 per 100 000) except Japan and low in most of the developing regions (less than 40 per 100 000). Although developed countries have high incidence rates, in the transition countries like Latin America, it is going to be increased in the future. The rates vary worldwide, with Europe being the highest. The rates are increasing in Latin America and Asian countries mainly due to the population aging and screening practices.

The total number of cases registered for five year period 1998-2002 were 13 120 964 (6 848 973 men and 6 271 991 women), the average of annual cases registered to be about 1 250 000 for women and 1 369 795 for men. During this period, 1 775 353 cases of breast cancer were registered worldwide. The highest rates occurred in Europe (Belgium, France, Switzerland, Italy) and in Australia with average rates of 60-100/100 000 cases. The lowest ASR (W) was between 18-30/100 000 in India, Thailand, China and Africa (Harare and Kyadondo).

 

Canada Breast Cancer Statistics

26,300 women were diagnosed with breast cancer. This represents 25% of all new cancer cases in women in 2017.  5,000 women died from breast cancer. This represents 13% of all cancer deaths in women in 2017.

On average, 72 Canadian women were diagnosed with breast cancer every day. On average, 14 Canadian women died from breast cancer every day. 230 men were diagnosed with breast cancer and 60 died from breast cancer.
 

About 12% of Canadian women (1 in 8) will develop breast cancer over the course of her lifetime. In 2017, an estimated 266,110 new cases of invasive and 63,960 new cases of non-invasive (in situ) breast cancer are expected to be diagnosed.

 

After increasing incidence rates of breast cancer for the previous two decades, it began decreasing in the year 2000 and dropped by 7% from 2002 to 2003 alone. This decrease was partially due to the reduced use of hormone replacement therapy (HRT) by women after results of a large study called Women’s Health Initiative which was published in the year 2002. These results suggested a relation between HRT and increased breast cancer risk.

 

Though death rates have been decreased since 1989, about 40,610 women are expected to die in the year 2017 in the U.S. from breast cancer. Women under the age of 50 have experienced larger decreases. These decreases are thought to be the result of treatment advances, earlier detection through screening and increased awareness.

Besides skin cancer, breast cancer is the most commonly diagnosed cancer among American women. In 2017, it is estimated that about 30% of new cases diagnosed in women will be breast cancers.

Breast cancer is more common in African-American women than in white women under the age 45. Overall, African-American women are more likely to die of breast cancer. For Asian, Hispanic and Native-American women, the risk of developing and dying from breast cancer is lower. As many as 40 % cases more cases are predicted by 2030.

 

The risk of breast cancer in women doubles, if she has a first-degree relative (mother, sister or daughter) who has been diagnosed with breast cancer. Less than 15% of women who get breast cancer have a family member diagnosed with it.

About 5-10% of breast cancer is linked to gene mutations (abnormal changes) inherited from one’s mother or father. Mutations of BRCA1 and BRCA2 genes are the most common ones. On an average, women with the BRCA1 mutation have a 55-65% lifetime risk of developing breast cancer. The risk is 45% for the women with the BRCA2 mutation. Breast cancer that is positive for the BRCA1 and BRCA2 mutations tends to develop more often in younger women. An increased ovarian cancer risk is also associated with these genetic mutations. In men, BRCA2 mutations are associated with a lifetime breast cancer risk of about 6.8%, BRCA1 mutations are a less frequent cause of breast cancer in men.

The objective behind the Conference

The main objective of holding Breast Pathology and Cancer Diagnosis 2019 conference is to share the latest research and developments of individuals in the sphere of cancer, which helps to develop new techniques for the treatment and can also discuss and plan to reduce the use of chemotherapy treatment by introducing special drugs that will continue to develop and directly attack special targeted breast cancer cells.

Pharmaceutical Companies Leading the Breast Cancer Fight

  • Bristol-Myers Squibb Co. (NYSE: BMY)
  • Merck & Co. Inc. (NYSE: MRK)
  • Medivation Inc. (NASDAQ: MDVN)
  • Pfizer Inc. (NYSE: PFE)

Breast Cancer Associations & Societies around the Globe

1.         American Cancer Society

2.         American Medical Women's Association

3.         American Society for Radiation Oncology

4.         American Society of Paediatric Hematology/Oncology

5.         Association of Cancer Physicians

6.         Association of Chartered Physiotherapists in Women’s Health

7.         Association of Women's Health, Obstetric and Neonatal Nurses

8.         Breast Screen Australia Program

9.         Cancer Relief Society Nepal

10.       Cancer Society of Finland

11.       Cancer Society of New Zealand

12.       Caribbean Women's Health Association

13.       European Association for Cancer Research (EACR)

14.       Indonesian Society of Gynecologic Oncology

15.       International Association for Women's Mental Health

16.       International Gynecologic Cancer Society

17.       Iranian Society of Radiation Oncology

18.       Japanese Breast Cancer Society

19.       New Zealand Breast Cancer Foundation (NZBCF)

20.       Society for Women's Health Research

21.       Spanish Association for Cancer Research (CMA)

22.       Thai Gynecologic Cancer Society

 

Past Conference Report

Breast Cancer 2019

Gratitude’s to all of our honourable speakers, conference attendees and sponsors. Breast Cancer 2019 Conference was our best ever!

9th World Congress on Breast Cancer Conference, hosted by the Conference Series LLC ltd was held during April 25-26, 2019, London, UK with the theme “Determining the possible ways to cure and prevent breast cancer”. Magnanimous response and active participation was received from the Editorial Board Members of conference series as well as from the Scientists, Doctors, Professors, Oncologists, Radiologists, Pharmaceutical Industries, Healthcare Industries, Researchers and Students from the field of Breast Cancer, who made this event successful.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

  • Breast Cancer- Present Perspective
  • Breast Cancer Therapy, Prevention and Management
  • Surgery Choices for Breast Cancer
  • Screening, Detecting, and Diagnosing Breast Cancer
  • Breast Cancer Nursing
  • Personalized Medicine - A Redefined Treatment

The conference was initiated with a series of lectures delivered by both Honourable Guests and members of the Keynote forum. The list included:

Geert C. Mudde
OncoQR ML GmbH, Austria

Kim O’Neill
Brigham Young University, USA

Cristian Scatena
University of Pisa, Italy

Pascale A. Cohen
Centre de Recherche en Cancérologie de Lyon, France

With the grand success of Breast Cancer-2019, Conference Series LLC is proud to announce the "10th World Congress on Breast Cancer” to be held during April 20-21, 2020 Venue : Berlin, Germany.

For more information please visit: http://breastcancer.conferenceseries.com/

 


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date April 20-21, 2020

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Breast Cancer: Current Research Journal of Carcinogenesis & Mutagenesis Journal of Cancer Science & Therapy

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Keytopics

  • Against Breast Cancer
  • Anatomy Of The Breast
  • Biopsy
  • BRCA Genes
  • Breast Augmentation
  • Breast Calcification
  • Breast Cancer & Stem Cells
  • Breast Cancer And The Internet
  • Breast Cancer Areola
  • Breast Cancer Awareness
  • Breast Cancer Biology
  • Breast Cancer Causes
  • Breast Cancer Clinics
  • Breast Cancer Daignosis
  • Breast Cancer Diagnosis & Early Signs
  • Breast Cancer During Pregnancy
  • Breast Cancer Glossary
  • Breast Cancer Health Aspects And Complications
  • Breast Cancer Hormonal Therapy
  • Breast Cancer Hospitals
  • Breast Cancer Immune Tolerance
  • Breast Cancer Immunology & Immunotherpay
  • Breast Cancer In Young Women
  • Breast Cancer Local Treatment Options
  • Breast Cancer Lumpectomy
  • Breast Cancer Lumps
  • Breast Cancer Pain Q & A
  • Breast Cancer Pathology
  • Breast Cancer Pharmacology
  • Breast Cancer Prevention
  • Breast Cancer Protecting Fertility
  • Breast Cancer Quiz Whats Your Risk
  • Breast Cancer Radiation Therapy
  • Breast Cancer Recurrence
  • Breast Cancer Research
  • Breast Cancer Research
  • Breast Cancer Resources
  • Breast Cancer Risk
  • Breast Cancer Risk Factors
  • Breast Cancer Screening
  • Breast Cancer Screening Guideline
  • Breast Cancer Second Opinion Q & A
  • Breast Cancer Statistics
  • Breast Cancer Support
  • Breast Cancer Surgery
  • Breast Cancer Surgery
  • Breast Cancer Symptoms
  • Breast Cancer Therapy
  • Breast Cancer Treatment
  • Breast Cancer Vaccine
  • Breast Cells
  • Breast Diseases And Breast Cancer
  • Breast Lobules
  • Breast Reconstruction
  • Breast Reconstruction
  • Breast Self Examination
  • Breast Tumors
  • Breastcancer Chemotherapy
  • Cancer Susceptability
  • Cancer Units
  • Carcinoma
  • Carcinoma In Situ
  • Chemotherapy For Breast Cancer
  • Doctors Who Treat Breast Cancer
  • Duct
  • Follow Up Care After Breast Cancer Surgery
  • Genetic Counselling
  • I've Found A Breast Lump
  • Implant
  • Inflammatory Breast Cancer
  • Intraoperative Radiation Therapy For Breast Cancer
  • Localized Cancer
  • Lumpectomy
  • Magnetic Resonance Imaging (MRI)
  • Male Breast Cancer
  • Mastectomy
  • Medications To Reduce The Risk Of Breast Cancer
  • Minimally Invasive Breast Biopsy
  • MRI And Breast Cancer
  • Novel Approaches To Breast Cancer
  • Oncologists
  • Oncology
  • Plastic Surgeon
  • Radiation Therapy For Breast Cancer
  • Recurrent Breast Cancer
  • Tamoxifen And Breast Cancer
  • Target Therapy
  • The Diagnosis Is Breast Cancer
  • The Role Of Ethnicity And Race In Breast Cancer Risk
  • Ultrasonography
  • Understanding Benign Breast Disease
  • What If They Think They See Something On My Mammogram
  • What Is The Benefit Of BRCA Genetic Testing